Company name:Thiogenesis Therapeutics, Corp. (formerly Rozdil Capital Corporation)
Document type:52-109FV1 - Certification of annual filings - CEO (E)
Project number:03403629
Filing date:06-28-2022
This is not the latest filing of type "52-109FV1 - Certification of annual filings - CEO (E)" for the IssuerShow the latest document View all the latest filings by Thiogenesis Therapeutics, Corp. (formerly Rozdil Capital Corporation)